IκBα gene therapy in tumor necrosis factor-α- and chemotherapy-mediated apoptosis of hepatocellular carcinomas

Cancer Gene Therapy

Volumn 7, Issue 10, 2000, Pages 1315-1323

  Tietze, Maja Katrin ^a   Wuestefeld, Torsten ^a   Paul, Yasmin ^a   Zender, Lars ^a   Trautwein, Christian ^a   Manns, Michael Peter ^a   Kubicka, Stefan ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Apoptosis; Hepatocellular carcinoma; Nuclear factor B

Indexed keywords

CYTOKINE; CYTOTOXIC AGENT; DOXORUBICIN; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; CASPASE; DNA BINDING PROTEIN; FAS LIGAND; FASLG PROTEIN, HUMAN; I KAPPA B; MEMBRANE PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE TARGETING; GENE THERAPY; HEPATOMA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; LIVER CARCINOMA; LIVER CELL; LIVER REGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPRESSOR GENE; ADENOVIRUS; AGAR GEL ELECTROPHORESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING;

ADENOVIRIDAE; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASPASES; DNA-BINDING PROTEINS; DOXORUBICIN; DRUG RESISTANCE; ELECTROPHORESIS, AGAR GEL; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE THERAPY; HUMANS; I-KAPPA B PROTEINS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033626443     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700247     Document Type: Article

References (34)

1. Apoptosis in cancer therapy: Crossing the threshold
2. Shifting the cancer paradigm: Must we kill to cure?
3. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II
4. Apoptosis signaling by death receptors
5. A novel domain within the 55-kDa TNF receptor signals cell death
6. A novel protein required for apoptosis: Mutational analysis of human Fas antigen
7. Embryonic lethality and liver degeneration in mice lacking the RelA component of NFκB
8. NFκB prevents apoptosis and liver dysfunction during liver regeneration
9. Severe liver degeneration in mice lacking the iκB kinase 2 gene
10. Rapid proteolysis of iκB is necessary for activation of transcription factor NFκB
11. An essential role of NFκB in preventing TNF-α-induced cell death
12. Suppression of TNF-α-induced apoptosis by NFκB
13. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
14. Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells
15. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NFκB
16. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
17. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (Apo-1/Fas) receptor/ligand system and involves activation of wild-type p53
18. Structure of the promoter for the Fas antigen gene
19. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T-lymphocytes via activation of NFκB and AP-1
20. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: Functional analysis in T cell hybridoma
21. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-κB p50-p65 recruitment
22. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB
23. Apoptosis: Molecules and mechanisms
24. NF-κB: A lesson in family values
25. Suppression of tumor necrosis factor-induced cell death by inhibition of apoptosis c-IAP2 is under NF-κB control
26. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis
27. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
28. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival
29. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis
30. Death receptors: Signaling and modulation
31. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways
32. Cellular commitment to oncogene-induced transformation or apoptosis is dependent of the transcription factor IRF-1
33. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKG gene: Role of IRF-1 and NFκB
34. The structure and complete sequence of the murine gene encoding interleukin-1β converting enzyme (ICE)